Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 21:15:5729-5740.
doi: 10.2147/IJGM.S360160. eCollection 2022.

Different Aspects of Diabetes in Hospitalized Patients with COVID-19

Aml Ahmed Sayed  1 , Hossam Hassan Abdelfatah  1 , Marwa Ahmed Abdelhameid  1 , Omaima Mohamed Ali  1
Affiliations

Different Aspects of Diabetes in Hospitalized Patients with COVID-19

Aml Ahmed Sayed et al. Int J Gen Med. .

Abstract

Background: The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) causes COVID-19, a recent infectious disease that aggravates the underlying pathophysiology of hyperglycemia in diabetic individuals. This study aimed to detect how diabetes mellitus (DM) affected COVID-19 patients' morbidity and mortality, and the incidence of neonset DM.

Patients and methods: The present study was a cross-sectional study done at Aswan Isolation Hospitals, Egypt. It comprised 200 individuals who had been tested positive for COVID-19. They were divided into two groups: group 1 (pre-existing diabetes = 143 patients) and group 2 (new-onset diabetes = 57 patients), and all patients were subjected to general examinations, hospital stay duration, and investigations, such as (complete blood count, urea, creatinine, HBA1c, fasting, postprandial, and random blood sugar, D-Dimer, ferritin, C-reactive protein, PCR for SARS COV-2 RNA, and CT chest.

Results: The current study consisted of 94 males and 106 females. According to disease severity, they were 96 (48.0%) critical cases, 57 (28.5%) severe cases, and 47 (23.5%) non-severe cases. The incidence of new-onset DM in COVID-19 patients was 28.5% (57 new cases), with a mortality rate of 42.0% (84 cases). Regarding glycemic control, we found a significant difference in fasting blood sugar (FBS) between the two groups, with a significant increase of FBS in the dead group than in the survived group. We also found a significant age difference in critical than in severe and non-severe groups, with a high mortality rate in older patients. Inflammatory markers, such as ferritin, CRP, and D-dimer, were higher in critical than in severe and non-severe groups.

Conclusion: The prevalence of new-onset DM is significant among hospitalized COVID-19 patients. Older patients were more prone to disease severity with high mortality rate. Inflammatory markers such as CRP and ferritin were significantly related to the COVID-19 severity and outcome.

Keywords: COVID-19; diabetes mellitus; disease severity; morbidity; mortality rate.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Shows the difference between disease severity and Age.
Figure 2
Figure 2
Shows the difference between Ferritin and patients’ outcome (Recovery - death) (P 0.001).
Figure 3
Figure 3
Shows the difference between D-dimer and patients’ outcome (Recovery - death) (P 0.000).
Figure 4
Figure 4
Kaplan–Meier survival analysis according to diabetes status, p-value obtained from Log Rank Mantel–Cox test.
See this image and copyright information in PMC

References

    1. Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450–452. doi:10.1038/s41591-020-0820-9 - DOI - PMC - PubMed
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. - PMC - PubMed
    1. Chow N, Fleming-Dutra K, Gierke R, et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382–386. doi:10.15585/mmwr.mm6913e2 - DOI - PMC - PubMed
    1. Chee YJ, Ng SJH, Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020;4:108166. - PMC - PubMed
    1. Chee YJ, Tan SK, Yeoh E. Dissecting the interaction between COVID‐19 and diabetes mellitus. J Diabetes Investig. 2020;11(5):1104. doi:10.1111/jdi.13326 - DOI - PMC - PubMed